Literature DB >> 1500155

Staphylococcal alpha toxin: a study with chronically instrumented awake sheep.

S Harshman1, P L Lefferts, J R Snapper.   

Abstract

The in vivo responses to staphylococcal alpha toxin are reported for 15 chronically instrumented awake yearling sheep. The data obtained from a total of 30 experiments are grouped into four categories of response: no response, noted in seven experiments done on 5 sheep; pressor response, obtained seven times in 4 sheep; fluid and solute exchange, noted on six occasions in 3 sheep; and acute heart failure and death, which occurred in 10 of the 15 sheep. "No response" denoted no change in any of the measured outcome variables. The group of sheep labeled as showing "pressor response" responded to alpha toxin infusion with an increase in pulmonary artery pressure, unaccompanied by changes either in lung lymph flow or in lung mechanics. "Changes in lung fluid and solute exchange" involve increases in lung lymph flow. The harbinger of the last category, acute left heart failure leading to death, was a marked elevation in left atrial pressure. The threshold response dose in sheep is approximately 21 micrograms/kg. A very steep dose-response curve is observed, with only a narrow window of doses, 15 to 25 micrograms/kg, between the group showing no response and the group showing death from acute heart failure. The data obtained in these studies indicate that the lethal effects of alpha toxin in sheep include acute heart failure, which may be due to direct toxicity to heart muscle and/or the coronary vasculature endothelium.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1500155      PMCID: PMC257349          DOI: 10.1128/iai.60.9.3489-3496.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  29 in total

1.  Quantitative analysis of the binding and oligomerization of staphylococcal alpha-toxin in target erythrocyte membranes.

Authors:  J Reichwein; F Hugo; M Roth; A Sinner; S Bhakdi
Journal:  Infect Immun       Date:  1987-12       Impact factor: 3.441

2.  Preparation and purification of staphylococcal alpha toxin.

Authors:  S Harshman; N Sugg; P Cassidy
Journal:  Methods Enzymol       Date:  1988       Impact factor: 1.600

3.  Enzyme-linked immunosorbent assay (ELISA). Quantitative assay of immunoglobulin G.

Authors:  E Engvall; P Perlmann
Journal:  Immunochemistry       Date:  1971-09

4.  Action of staphylococcal alpha-toxin on membranes: some recent advances.

Authors:  S Harshman
Journal:  Mol Cell Biochem       Date:  1979-02-09       Impact factor: 3.396

5.  Direct and indirect effects of leukotriene D4 on the lungs of unanesthetized sheep.

Authors:  M L Ogletree; J R Snapper; K L Brigham
Journal:  Respiration       Date:  1987       Impact factor: 3.580

6.  Reaction of staphylococcal alpha-toxin with peptide-induced antibodies.

Authors:  S Harshman; J E Alouf; O Siffert; F Baleux
Journal:  Infect Immun       Date:  1989-12       Impact factor: 3.441

7.  The role of cyclooxygenase products in lung injury induced by tumor necrosis factor in sheep.

Authors:  A P Wheeler; W D Hardie; G R Bernard
Journal:  Am Rev Respir Dis       Date:  1992-03

8.  Membrane damage by staphylococcal alpha-toxin to different types of cultured mammalian cell.

Authors:  M Thelestam
Journal:  Biochim Biophys Acta       Date:  1983-07-14

9.  Human hyperimmune globulin protects against the cytotoxic action of staphylococcal alpha-toxin in vitro and in vivo.

Authors:  S Bhakdi; U Mannhardt; M Muhly; F Hugo; H Ronneberger; K D Hungerer
Journal:  Infect Immun       Date:  1989-10       Impact factor: 3.441

10.  Inactivation of the alpha-haemolysin gene of Staphylococcus aureus 8325-4 by site-directed mutagenesis and studies on the expression of its haemolysins.

Authors:  M O'Reilly; J C de Azavedo; S Kennedy; T J Foster
Journal:  Microb Pathog       Date:  1986-04       Impact factor: 3.738

View more
  1 in total

1.  Induction of muscle-relaxing factor by staphylococcal alpha-toxin.

Authors:  S Harshman; N Sugg
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.